Jenny focuses her practice on mergers and acquisitions and advising boards of directors on fiduciary duty and other corporate governance matters. Jenny’s clients have included Afterpay, Astra Space, Atlas Air Worldwide, bp, Cable One, Canadian National Railway, Cincinnati Bell, City Brewing, CommScope, Crown Castle, Exyte, GW Pharmaceuticals, Johnson & Johnson, Light & Wonder, Moda Operandi, NCR, Novartis, Pitney Bowes, Royal Caribbean, Scientific Games, Time Warner, US Foods, Viatris and Yahoo.
Jenny has consistently been recognized as a leading advisor by numerous publications and legal directories. Recently, Jenny was named to the Lawdragon 500 Leading Dealmakers in America list for M&A and Corporate Governance. In 2024, she was named "Dealmaker of the Year" by The American Lawyer and included on the “Private Practice Powerlist” by Legal 500. She is ranked among leading Corporate/M&A lawyers in New York by Chambers USA, as a “Thought Leader” by Who’s Who Legal: M&A and Governance and a “Highly Regarded” M&A lawyer by IFLR1000. Jenny was named as a Rising Star: Mergers and Acquisitions by Law360 in 2022, recognizing her as one of six outstanding M&A lawyers in the nation under the age of 40. In 2021 and 2022, she was shortlisted for the “M&A Lawyer of the Year” award at Euromoney Legal Media Group’s Americas Women in Business Law Awards. In 2022 and 2023, Jenny was named to Crain’s New York Business’ list of “Notable...
- Afterpay on its $29 billion sale to Block (formerly Square).
- The Special Committee of the Board of Directors of Astra Space on its all-cash take-private of Astra Space.
- Atlas Air Worldwide on its long‑term commercial agreements to provide air cargo services to Amazon, and its grant of rights to Amazon to acquire Atlas Air equity.
- bp on its $4.1 billion take-private of Archaea Energy.
- The Special Committee of Bakkt on its pending acquisition of Distributed Technologies Research Ltd.
- Sparklight (formerly Cable One) on its $2.2 billion acquisition of Hargray Communications, $525.9 million acquisition of Fidelity Communications’ data, video and voice business, acquisition of Clearwave Communications, and $735 million acquisition of NewWave Communications.
- Canadian National Railway on its $33.6 billion interloper bid for Kansas City Southern.
- Cincinnati Bell on its $2.9 billion sale to Macquarie Infrastructure.
- City Brewing on an equity investment, as a result of which a consortium of investors acquired 100% ownership of the company, and its acquisition of the Irwindale brewery operations from Pabst Brewing.
- The Special Committee of the Board of Directors of CNH Global in connection with the merger of Fiat Industrial and CNH Global with CNH Industrial.
- CommScope on its receipt of a $1 billion investment from The Carlyle Group in connection with its $7.4 billion acquisition of ARRIS.
- Coupa on its $8 billion sale to Thoma Bravo.
- Exyte on its acquisitions of Airgard, Inc. and Critical Process Systems and its acquisition of CollabraTech Solutions.
- GKN on the £8.1 billion unsolicited offer from Melrose and proposed $6.1 billion combination of its Driveline business with Dana.
- GW Pharmaceuticals on its $7.2 billion sale to Jazz Pharmaceuticals.
- Johnson & Johnson on numerous transactions, including its $13.1 billion acquisition of Shockwave Medical, Inc., separation of its Consumer Health business, $6.5 billion acquisition of Momenta, Janssen Biotech’s $750 million acquisition of bermekimab from XBiotech, $2.8 billion sale of its Advanced Sterilization Products business to Fortive, and $2.1 billion sale of its LifeScan business to Platinum Equity.
- Light & Wonder (previously Scientific Games) on its $6.05 billion sale of SG Lottery to Brookfield, sale of OpenBet to Endeavor, $925.5 million sale of a 34.9% stake to institutional investors, acquisition of Don Best Sports, and C$775 million acquisition of NYX Gaming Group.
- Lowe’s on its $8.8 billion acquisition of Foundation Building Materials.
- Merck on its $10 billion acquisition of Verona Pharma plc.
- Moda Operandi on its recapitalization by a consortium of investors.
- Novartis on numerous transactions including its acquisition of Mariana Oncology, acquisition of DTx Pharma for an upfront payment of $500 million and additional milestone payments and its €2.7 billion acquisition of MorphoSys AG.
- Roivant Sciences on its $7.1 billion sale of Telavant to Roche and its $1.2 billion sale of Dermavant to Organon.
- Sanofi S.A. on its pending acquisition of Vigil Neuroscience, Inc.
- Standard BioTools Inc. on its strategic pending sale of SomaLogic to Illumina, Inc. for an aggregate cash consideration of up to $425 million.
- Time Warner on its $109 billion sale to AT&T.
- The strategic review committee of the board of directors of Yahoo! in the $4.5 billion acquisition of Yahoo!’s operating business by Verizon.
- US Foods on its receipt of a $500 million convertible preferred equity investment from KKR and $970 million acquisition of Smart Foodservice.
3 World Trade Center
175 Greenwich Street, 51st Floor